AWA
LGND icon

Arkadios Wealth Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Arkadios Wealth Advisors’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-16
Closed – – 1696
2020
Q4 		$0 Hold
16
– – ﹤0.01% 1418
2020
Q3 		$973 Hold
16
– – ﹤0.01% 966
2020
Q2 		$1.19K Hold
16
– – ﹤0.01% 893
2020
Q1 		$727 Hold
16
– – ﹤0.01% 988
2019
Q4 		$957 Buy
+16
New +$1.07K ﹤0.01% 896

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Arkadios Wealth Advisors's LGND Position: Q1 2021 in Review

Arkadios Wealth Advisors sold out of Ligand Pharmaceuticals (LGND) in Q1 2021, closing a stake of 16 shares.

Arkadios Wealth Advisors first reported a position in LGND in Q4 2019 and held it in 5 quarters. The position peaked at $1.19K in Q2 2020. 228 funds tracked by Wall St. Rank hold LGND as of Q1 2021.

  • Arkadios Wealth Advisors reported no remaining Ligand Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Arkadios Wealth Advisors sold 16 Ligand Pharmaceuticals shares in Q1 2021.
  • Arkadios Wealth Advisors first reported a position in Ligand Pharmaceuticals in Q4 2019 and held it in 5 quarters.
  • Arkadios Wealth Advisors's Ligand Pharmaceuticals position peaked at $1.19K in Q2 2020.
  • 228 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2021.

Based on Arkadios Wealth Advisors's 13F filing for Q1 2021, filed 26 Apr 2021.